Although the optimal cytokine cocktail has not been established, insights into AD-like therapeutic responses have been obtained by combining IL-4 and IL-13 with one or more of the above-mentioned stimulating agents [23,24]. This evidence concerns the gene IL13 and Alzheimer disease.